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Entecavir (ETV), an analogue of guanosine, is a highly efficient anti-hepatitis B antiviral drug. 
It is the first-line therapy for both adults and children. Its use in pregnancy is limited 
due to a number of factors, including lack of data on placental pharmacokinetics. The placental 
transition of drugs is frequently controlled by drug transporters. ATP-binding (ABC) 
transporters, P-glycoprotein (P-gp), breast cancer resistance protein (BCRP) or multidrug 
resistance-associated protein 2 (MRP2) localized in the apical membrane 
of syncytiotrophoblast and pumping their substrates in the feto-maternal direction belong to 
most significant determinants of placental pharmacokinetics. Moreover placental transport of 
nucleoside-derived drugs can be affected by the activity of nucleoside transporters (NTs); 
equilibrative nucleoside transporters (ENTs) mediate facilitated diffussion, while the 
concentrative nucleoside transporters (CNTs) control active influx of their substrates. 
The aim of the diploma thesis was to describe the role of P-gp, BCRP, MRP2 and NTs (ENTs 
and CNTs) in placental transfer of ETV. For this purpose, an in vitro transport method was 
performed on MDCKII cells expressing the human P-gp, BCRP or MRP2 and the accumulation 
method performed using BeWo cell line derived from placental choriocarcinoma. We found 
that ETV is not a substrate of P-gp, BCRP or MRP2, but we have confirmed that it is a substrate 
of ENT1. it can be conluded that ENT1 might contribute to ETV placental transfer. Further 
experiments on more complex models are, however, needed to fully describe the ETV placental 
pharmacokinetics and the practical application of these findings. 
 
